These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23372154)

  • 1. Rabbit antithymocyte globulin and cyclosporine as first-line therapy for children with acquired aplastic anemia.
    Takahashi Y; Muramatsu H; Sakata N; Hyakuna N; Hamamoto K; Kobayashi R; Ito E; Yagasaki H; Ohara A; Kikuchi A; Morimoto A; Yabe H; Kudo K; Watanabe K; Ohga S; Kojima S;
    Blood; 2013 Jan; 121(5):862-3. PubMed ID: 23372154
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine.
    Lan Y; Chang L; Yi M; Cai Y; Feng J; Ren Y; Liu C; Chen X; Wang S; Guo Y; Zhang A; Liu L; Zhang J; Zhu X
    Ann Hematol; 2021 Jan; 100(1):53-61. PubMed ID: 33033910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified immunosuppressive therapy with porcine antilymphocyte globulin plus delayed cyclosporine A in children with severe aplastic anemia.
    Cui Q; Sha P; Chen H; Shen H; Qin L; Li Z; Wu T; Wang Z
    Int J Hematol; 2018 Jan; 107(1):64-68. PubMed ID: 28900860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.
    Clé DV; Atta EH; Dias DSP; Lima CBL; Bonduel M; Sciuccati G; Medeiros LA; de Oliveira MM; Blum Fonseca PB; Saad STO; Hamerschlak N; Salvino MA; Garanito MP; Pazin-Filho A; Scheinberg P; Calado RT
    Ann Hematol; 2018 Nov; 97(11):2039-2046. PubMed ID: 29978284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.
    Jeong DC; Chung NG; Cho B; Zou Y; Ruan M; Takahashi Y; Muramatsu H; Ohara A; Kosaka Y; Yang W; Kim HK; Zhu X; Kojima S
    Haematologica; 2014 Apr; 99(4):664-71. PubMed ID: 24213150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia.
    Osugi Y; Yagasaki H; Sako M; Kosaka Y; Taga T; Ito T; Yamamoto M; Ohara A; Sato T; Mimaya J; Tsukimoto I; Kojima S;
    Haematologica; 2007 Dec; 92(12):1687-90. PubMed ID: 18055993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabbit-antithymocyte globulin combined with cyclosporin A as a first-line therapy: improved, effective, and safe for children with acquired severe aplastic anemia.
    Chen C; Xue HM; Xu HG; Li Y; Huang K; Zhou DH; Guo HX; Fang JP; Huang SL
    J Cancer Res Clin Oncol; 2012 Jul; 138(7):1105-11. PubMed ID: 22402596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of optimized over standard protocol of rabbit antithymocyte globulin for severe aplastic anemia: a single-center experience.
    Li X; Shi J; Ge M; Shao Y; Huang J; Huang Z; Zhang J; Nie N; Zheng Y
    PLoS One; 2013; 8(3):e56648. PubMed ID: 23554855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A.
    Garanito MP; Carneiro JD; Odone Filho V; Scheinberg P
    J Pediatr (Rio J); 2014; 90(5):523-7. PubMed ID: 24878006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia.
    Atta EH; Lima CBL; Dias DSP; Clé DV; Bonduel MM; Sciuccati GB; Medeiros LA; Oliveira MM; Salvino MA; Garanito MP; Blum Fonseca PB; Saad STO; Calado RT; Scheinberg P
    Ann Hematol; 2017 Nov; 96(11):1907-1914. PubMed ID: 28815305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children.
    Yoshimi A; Niemeyer CM; Führer MM; Strahm B
    Blood; 2013 Jan; 121(5):860-1. PubMed ID: 23372153
    [No Abstract]   [Full Text] [Related]  

  • 12. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.
    Frickhofen N; Heimpel H; Kaltwasser JP; Schrezenmeier H;
    Blood; 2003 Feb; 101(4):1236-42. PubMed ID: 12393680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early intensified intravenous cyclosporine therapy predicts favorable response to immunosuppressive therapy with rabbit antithymocyte globulin in patients with severe aplastic anemia.
    Song MK; Chung JS; Joo YD; Lee GW; Hong J; Park SH; Shin HJ
    Leuk Res; 2015 Mar; 39(3):284-9. PubMed ID: 25563075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive therapy for aplastic anemia: a single-center experience from western India.
    Shah S; Jain P; Shah K; Patel K; Parikh S; Patel A; Panchal H; Anand A
    Ann Hematol; 2019 Jan; 98(1):41-46. PubMed ID: 30173288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia.
    Chang MH; Kim KH; Kim HS; Jun HJ; Kim DH; Jang JH; Kim K; Jung CW
    Eur J Haematol; 2010 Feb; 84(2):154-9. PubMed ID: 19912311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
    Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.
    Hayakawa J; Kanda J; Akahoshi Y; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Yamazaki R; Kako S; Kanda Y
    Int J Hematol; 2017 May; 105(5):578-586. PubMed ID: 28078653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithymocyte globulin and cyclosporin in children with acquired aplastic anemia.
    Gupta V; Bhatia B
    Indian J Pediatr; 2009 Sep; 76(9):970-1; author reply 971-2. PubMed ID: 19381516
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study.
    Atta EH; Dias DS; Marra VL; de Azevedo AM
    Ann Hematol; 2010 Sep; 89(9):851-9. PubMed ID: 20373101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.